請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/60056
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 蔡懷楨(Huai-Jen Tsai) | |
dc.contributor.author | You-Jei Chen | en |
dc.contributor.author | 陳侑頡 | zh_TW |
dc.date.accessioned | 2021-06-16T09:53:16Z | - |
dc.date.available | 2020-02-08 | |
dc.date.copyright | 2017-02-08 | |
dc.date.issued | 2016 | |
dc.date.submitted | 2017-01-10 | |
dc.identifier.citation | Abdesselem, H., Shypitsyna, A., Solis, G. P., Bodrikov, V., Stuermer, C. A. (2009) 'No Nogo66- and NgR-mediated inhibition of regenerating axons in the zebrafish optic nerve', The Journal of Neuroscience 29(49):15489-15498.
Atwal, J. K., Gosse, J. P., Syken, J., Stawicki, S., Wu, Y., Shatz, C., Lavigne, M. T. (2008) 'PirB is a functional receptor for myelin inhibitors of axonal regeneration', Science 322(5903): 967-970. Ayala, Y. M., Misteli, T., Baralle, F. E. (2008) 'TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression', Proceedings of the National Academy of Sciences 105(10):3785-3789. Balkwill, F. (2004) 'Cancer and the chemokine network', Nature Reviews Cancer 4(7):540-550 Bandtlow, C. E., Schmidt, M. F., Hassinger, T. D., Schwab, M. E., Kater, S. B. (1993) 'Role of intracellular calcium in NI-35-evoked collapse of neuronal growth cones', Science 259(5091): 80-83 Blake, C. C. F., Rice, D. W. (1981) 'Phosphoglycerate kinase', Philosophical Transactoins of the Royal Society B Biological Sciences 293(1063): 93-104. Blitterswijk, M., DeJesus-Hernandez, M., Rademakers, R. (2012) 'How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders? ', Current Opinion in Neurology 25(6):689-700. Blitterswijk, M., Es, M. A., Koppers, M., Rheenen, W., Medic, J., Schelhaas, H. J., Kooi, A. J., Visser, M., Veldink, J. H., Berg, L. H. (2012) 'VAPB and C9orf72 mutations in 1 familial amyotrophic lateral sclerosis patient', Neurobiology of Aging 33(12):2950.e1-4. Brosamle, C., Halpern, M. E. (2009) 'Nogo-Nogo receptor signalling in PNS axon outgrowth and pathfinding', Molecular and cellular neurosciences 40(4):401-409. Bruneteau, G., Bauche, S., Gonzalez de Aguilar, J. L., Brochier, G., Mandjee, N., Tanguy, M. L., Hussain, G., Behin, A., Khiami, F., Sariali, E., Hell-Remy, C., Salachas, F., Pradat, P. F., Lacomblez, L., Nicole, S., Fontaine, B., Fardeau, M., Loeffler, J. P., Meininger, V., Fournier, E., Koenig, J., Hantai , D. (2015) 'Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patient', Annals of Clinical and Translational Neurology 2(4):362-372. Buratti, E., Dork, T., Zuccato, E., Pagani, F., Romano, M., Baralle, F. E. (2001) 'Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping', The EMBO Journal 20(7):1774-1784. Buss, A., Sellhaus, B., Wolmsley, A., Noth, J., Schwab, M. E., Brook, G. A. (2005) 'Expression pattern of NOGO-A protein in the human nervous system', Acta Neuropathol 110(2): 113-119 Capitanio, D., Vasso, M., Ratti, A., Grignaschi, G., Volta, M., Moriggi, M., Daleno, C., Bendotti, C., Silani, V., Gelfi, C. (2012) 'Molecular signatures of amyotrophic lateral sclerosis disease progression in hind and forelimb muscles of an SOD1(G93A) mouse model', Antioxidants and Redox Signaling 17(10):1333-1350. Caroni, P., Schwab, M. E. (1988) 'Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibroblast spreading', Cell Biology 106(4): 1281-1288. Chen, M. S., Huber, A. B., van der Haar, M. E., Frank, M., Schnell, L., Spillmann, A. A., Christ, F. and Schwab, M. E. (2000) 'Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1', Nature 403(6768): 434-439. Chiarelli, L. R., Morera, S. M., Bianchi, P., Fermo, E., Zanella, A., Galizzi, A., Valentini, G. (2012) ' Molecular insights on pathogenic effects of mutations causing phosphoglycerate kinase deficiency', PLoS One 7(2): e32065 Cudkowicz, M. E., McKenna-Yasek, D., Sapp, P. E., Chin, W., Geller, B., Hayden, D. L., Schoenfeld, D. A., Hosler, B. A., Horvitz, H. R., Brown, R. H. (1997) 'Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis', Annals of Neurology 41(2):210-221. DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., Kouri, N., Wojtas, A., Sengdy, P., Hsiung, G. Y., Karydas, A., Seeley, W. W., Josephs, K. A., Coppola, G., Geschwind, D. H., Wszolek, Z. K., Feldman, H., Knopman, D. S., Petersen, R. C., Miller, B. L., Dickson, D. W., Boylan, K. B., Graff-Radford, N. R., Rademakers, R. (2011) ' Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS', Neuron 72(2):245-256. Dobrowolny, G., Aucello, M., Rizzuto, E., Beccafico, S., Mammucari, C., Boncompagni, S., Belia, S., Wannenes, F., Nicoletti, C., Del Prete, Z., Rosenthal, N., Molinaro, M., Protasi, F., Fano, G., Sandri, M., Musaro, A. (2008) 'Skeletal muscle is a primary target of SOD1G93A-mediated toxicity', Cell Metabolism 8(5):425-436. Domeniconi, M., Cao, Z., Spencer, T., Sivasankaran, R., Wang, K, C., Nikulina, E., Kumura, N., Cai, H., Deng, K., Gao, Y., He, Z., Fibin, M. T. (2002) 'Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth', Neuron 35(2): 283–290. Donnelly, C. J., Zhang, P. W., Pham, J. T., Haeusler, A. R., Mistry, N. A., Vidensky, S., Daley, E. L., Poth, E. M., Hoover, B., Fines, D. M., Maragakis, N., Tienari, P. J., Petrucelli, L., Traynor. B. J., Wang, J., Rigo, F., Bennett, C. F., Blackshaw, S., Sattler, R., Rothstein, J. D. (2013) 'RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention', Neuron 80(2):415-428. Dupuis, L., Gonzalez de Aguilar, J. L., di Scala, F., Rene, F., de Tapia, M., Pradat, P. F., Lacomblez, L., Seihlan, D., Prinjha, R., Walsh, F. S., Meininger, V., Loeffler, J. P. (2002) 'Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis', Neurobiology of Diseases 10(3):358-365. Fournier, A. E., GrandPre, T., Strittmatter, S. M. (2001) 'Identifcation of a receptor mediating Nogo-66 inhibition of axonal regeneration', Nature 409(6818): 341-646. Fratta, P., Mizielinska, S., Nicoll, A. J., Zloh, M., Fisher, E. M. C., Parkinson, G., AIsaacsb, A. M. (2012) ' C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes', Scientific Reports 2:1016 Fujita, Y., Endo, S., Takai, T., Yamashita, T. (2011) 'Myelin suppresses axon regeneration by Pir-B/SHP-mediated inhibition of Trk activity', The EMBO journal 30(7): 1389-1401. Gao, Y., Wang, B., Xiao, Z., Chen, B., Han, J., Wang, X., Zhang, J., Gao, S., Zhao, Y., Dai, J. (2010) 'Nogo-66 regulates nanog expression through stat3 pathway in murine embryonic stem cells', Stem Cells and Development 19(1): 53-60 Gendron, T. F., Rademakers, R., Petrucelli, L. (2013) 'TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43', Journal of Alzheimer's Disease 33(1): 35-45. GrandPre, T., Nakamura, F., Vartanian, T. and Strittmatter, S. M. (2000) 'Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein', Nature 403(6768): 439-444. Grunewald, E., Kinnell, H. L., Porteous, D.J., Thomson, P. A. (2009) 'GPR50 interacts with neuronal Nogo-A and affects neurite outgrowth', Molecular and Cellular Neuroscience 42(4):363-371 Halter, B., Gonzalez de Aguilar, J. L., Rene, F., Petri, S., Fricker, B., Echaniz-Laguna, A., Dupuis, L., Larmet, Y., Loeffler, J. P. (2010) 'Oxidative stress in skeletal muscle stimulates early expression of Rad in a mouse model of amyotrophic lateral sclerosis', Free Radical Biology and Medicine 48(7):915-923. Hannila, S. S., Filbin, M. T. (2010) 'The role of cyclic AMP signaling in promoting axonal regeneration after spinal cord injury', Experimental Neurology 209(2): 321-332 Harel, N. Y., Cudkowicz, M. E., Brown, R. H., Strittmatter, S. M. (2009) 'Serum Nogo-A levels are not elevated in amyotrophic lateral sclerosis patients', Biomarkers 14(6):414-417. Hegedus, J., Putman, C. T., Gordon, T. (2007) 'Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis', Neurobiology of Disease 28(2):154-164. Huber, A. B., Weinmann, O., Brosamle, C., Oertle, T. and Schwab, M. E. (2002) 'Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions', The Journal of Neuroscience 22(9): 3553-3567. Pinzon-Olejua, A., Welte, C., Abdesselem, H., Malaga-Trillo, E., Stuermer, C. A. O. (2014) 'Essential roles of zebrafish rtn4/Nogo paralogues in embryonic development', Neuronal Development 9: 8. Hu, F., Liu, B. P., Budel, S., Liao, J., Chin, J., Fournier, A., Strittmatter, S. M. (2005) 'Nogo-A interacts with the Nogo-66 receptor through multiple sites to create an isoform-selective subnanomolar agonist', The Journal of Neuroscience 25(22): 5298-5304. Hwang, T. L., Liang, Y., Chien, K. Y., Yu, J. S. (2006) 'Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma', Proteomics 6(7):2259-2272. Hsieh, S. H. K., Ferraro, G. B., Fournier, A. E. (2006) 'Myelin-associated inhibitors regulate cofilin phosphorylation and neuronal inhibition through LIM Kinase and slingshot phosphatase ', The Journal of Neuroscience 26(3): 1006-1015 Jokic, N., Gonzalez de Aguilar, J. L., Dimou, L., Lin, S., Fergani, A., Ruegg, M. A., Schwab, M. E., Dupuis, L., Loeffler, J. P. (2006) 'The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model', EMBO Reports 7(11):1162-1167 Jokic, N., Gonzalez de Aguilar, J. L., Pradat, P. F., Dupuis, L., Echaniz-Laguna, A., Muller, A., Dubourg, O., Seilhean, D., Hauw, J. J., Loeffler, J. P., Meininger, V. (2005) 'Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity', Annals of Neurology 57(4):553-556. Joset, A., Dodd, D. A., Halegoua, S., Schwab, M. E. (2010) 'Pincher-generated Nogo-A endosomes mediate growth cone collapse and retrograde signaling', Journal of Cell Biology 188(2): 271-285. Kanekura, K., Yagi, T., Cammack, A. J., Mahadevan, J., Kuroda, M., Harms, M. B., Miller, T. M., Urano, F. (2016) 'Poly-dipeptides encoded by the C9ORF72 repeats block global protein translation', Human Molecular Genetics 25(9):1803-1813. Kempf, A., Tews, B., Arzt, M. E., Weinmann, O., Obermair, F. J., Pernet, V., Zagrebelsky, M., Delekate, A., Iobbi, C., Zemmar, A., Ristic, Z., Gullo, M., Spies, P., Dodd, D., Gygax, D., Korte, M., Schwab, M. E. (2014) 'The Sphingolipid receptor S1PR2 is a receptor for Nogo-A repressing synaptic plasticity', PLOS Biology 12(1): e1001763 Kiernan, M. C, Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., Zoing, M. C. (2011) 'Amyotrophic lateral sclerosis', The Lancet 377(9769):942-955. Kim, J. E., Bonilla, I. E., Qui, D., Strittmatter, S. M. (2003) 'Nogo-C is sufficient to delay nerve regeneration', Molecular and Cellular Neuroscience 23(3): 451–459 Koprivica, V., Cho, K. S., Park, J. B., Yiu, G., Atwal, J., Gore, B., Kim, J. A., Lin, E., Tessier-Lavigne, M., Chen, D. F., He, Z. (2005) 'EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans', Science 310(5745): 106-110 Kuo, P. H., Doudeva, L. G., Wang, Y. T., Shen, C. K., Yuan, H. S. (2009) 'Structural insights into TDP-43 in nucleic-acid binding and domain interactions', Nucleic Acids Research 37(6):1799-1808. Lay, A. J., Jiang, X. M., Kisker, O., Flynn, E., Underwood, A., Condron, R., Hogg, P. J. (2000) 'Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase', Nature 408(6814):869-873. Magnusson, C., Libelius, R., Tagerud, S. (2003) 'Nogo (Reticulon 4) expression in innervated and denervated mouse skeletal muscle', Molecular and Cellular Neurosciences 22(3):298-307. Manns, R., Schmandke, A., Schmandke, A., Jareonsettasin, P., Cook, Geoffrey., Schwab, M. E., Holt, C., Keynes, R. (2014) 'Protein Synthesis Dependence of Growth Cone Collapse Induced by Different Nogo-A-Domains', PLOS one 9(1): e86820 Mantovani, V., Garagnani, P., Selva, P., Rossi, C., Ferrari, S., Cenci, M., Calza, N., Cerreta, V., Luiselli, D., Romeo, G. (2007) 'Simple method for haplotyping the poly(TG) repeat in individuals carrying the IVS8 5T allele in the CFTR gene', Clinical Chemistry 53(3):531-533. Marcuzzo, S., Zucca, I., Mastropietro, A., de Rosbo, N. K., Cavalcante, P., Tartari, S., Bonanno, S., Preite, L., Mantegazza, R., Bernasconi, P. (2011) 'Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a longitudinal MRI study', Experimental Neurology 231(1):30-37. McCord, J. M., Fridovich, I. (1969) 'Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein)', The Journal of Biological Chemistry 244(22):6049-6055. Meininger, V., Pradat, P. F., Corse, A., Al-Sarraj, S., Rix Brooks, B., Caress, J. B., Cudkowicz, M., Kolb, S. J., Lange, D., Leigh, P. N., Meyer, T., Milleri, S., Morrison, K. E., Orrell, R. W., Peters, G., Rothstein, J. D., Shefner, J., Lavrov, A., Williams, N., Overend, P., Price, J., Bates, S., Bullman, J., Krull, D., Berges, A., Abila, B., Meno-Tetang, G., Wurthner, J. (2014) 'Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trial', PLoS One 9(5):e97803. Mercado, P. A., Ayala, Y. M., Romano, M., Buratti, E., Baralle, F. E. (2005) 'Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene', Nucleic Acids Research 33(18):6000-6010. Michelson, A. M., Blake, C. C. F., Evans, S. T., Orkin, S. H. (1985) 'Structure of the human phosphoglycerate kinase gene and the intron-mediated evolution and dispersal of the nucleotide-binding domain', Proceedings of the National Academy of Sciences 82(20): 6965-6969. Mizielinska, S., Gronke, S., Niccoli, T., Ridler, C. E., Clayton, E. L., Devoy, A., Moens, T., Norona, F. E., Woollacott, I. O., Pietrzyk, J., Pietrzyk, J., Cleverley, K., Nicoll, A. J., Pickering-Brown, S., Dols, J., Cabecinha, M., Hendrich, O., Fratta, P., Fisher, E. M., Partridge, L., Isaacs, A. M. (2014) 'C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins', Science 345(6201):1192-1194. Montani, L., Gerrits, B., Gehrig, P., Kempf, A., Dimou, L., Wollscheid, B., Schwab, M. E. (2009) 'Neuronal Nogo-A modulates growth cone motility via Rho-GTP/LIMK1/cofilin in the unlesioned adult nervous system', The Journal of Biological Chemistry 284(16): 10793-10807. Mori, K., Weng, S. M., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H. A., Cruts, M., Van Broeckhoven, C., Haass, C., Edbauer, D. (2013) 'The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS', Science 339(6125):1335-1338. Muller, F. L., Liu, Y., Jernigan, A., Borchelt, D., Richardson, A., Van Remmen, H. (2008) 'MnSOD deficiency has a differential effect on disease progression in two different ALS mutant mouse models', Muscle and Nerve 38(3):1173-1183. Niederostst, B., Oertle, T., Fritsche, J., Mckinney, A., Bandtlow, C. E. (2002) 'Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1', The Journal of Neuroscience 22(23): 10368-10376 Pradat, P. F., Bruneteau, G., Gonzalez de Aguilar, J. L., Dupuis, L., Jokic N, Salachas F, Le Forestier N, Echaniz-Laguna A, Dubourg O, Hauw JJ, Tranchant C,Loeffler JP, Meininger V. (2007) 'Muscle Nogo-A expression is a prognostic marker in lower motor neuron syndromes', Annals of Neurology 62(1):15-20. Raman, R., Allen, S. P., Goodall, E. F., Kramer, S., Ponger, L. L., Heath, P. R., Milo, M., Hollinger, H. C., Walsh, T., Highley, J. R., Olpin, S., McDermott, C. J., Shaw, P. J., Kirby, J. (2015) 'Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions', Neuropathology and Applied Neurobiology 41(2):201-226. Renton, A. E., Chio, A., Traynor, B. J. (2014) 'State of play in amyotrophic lateral sclerosis genetics', Nature Neuroscience 17(1):17-23. Rocha, M. C., Pousinha, P. A., Correia, A. M., Sebastiao, A. M., Ribeiro, J. A. (2013) 'Early changes of neuromuscular transmission in the SOD1 (G93A) mice model of ALS start long before motor symptoms onset', PLoS One 8(9):e73846. Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donalson, D., Goto, J., O'Regan, J. P., Deng, H-X., Rahmani, Z., Krizus, A., McKenna-Yasek, D., Cayabyab, A., Gaston, S. M., Berger, R., Tanzi, R. E., Halperin, J. J., Herzfeldt, B., Van den Berg, R., Huang, W-Y., Bird, T., Deng, G., Mulder, D. W., Smyth, C., Laing, N. G., Soriano, E., Periacak-Vance, M. A., Haines, J., Rouleau, G. A., Gusella, J. S., Horvitz, H. R., Brown, R. H. (1993) 'Mutation in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis', Nature 362: 59-62. Schwab, M. E. (2010) 'Functions of Nogo proteins and their receptors in the nervous system ', Nature Reviews Neuroscience 11(12): 799-811 Shypitsyna, A., Malaga-Trillo, E., Reuter, A., Stuermer, C. A. O. (2011) 'Origin of Nogo-A by domain shuffling in an early jawed vertebrate', Molecular Biology and Evolution 28(4):1363-1370. Sivasankaran, R., Pei, J., Wang, K. C., Zhang, Y. P., Shields, C. B., Xu, X. M., He, Z. (2004) 'PKC mediates inhibitory effects of myelin and chondroitin sulfate proteoglycans on axonal regeneration', Nature Neuroscience 7(3): 261-268. Spencer, T., Domeniconi, M., Cao, Z., Filbin, M. T. (2003) 'New roles for old proteins in adult CNS axonal regeneration', Current Opinion in Neurobiology 13(1): 133-139. Spillmann, A. A., Bandtlow, C. E., Lottspeich, F., Keller, F., and Schwab, M. E. (1998) 'Identification and characterization of a bovine neurite growth inhibitor (bNI-220)', Biological Chemistry 273(30): 19283-19293. Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., Baralle, F., de Belleroche, J., Mitchell, J. D., Leigh, P. N., Al-Chalabi, A., Miller, C. C., Nicholson, G., Shaw, C. E. (2008) 'TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis', Science 319(5870):1668-1672. Strong, M. J., Volkening, K., Hammond, R., Yang, W., Strong, W., Leystra-Lantz, C., Shoesmith, C. (2007) 'TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein', Molecular and Cellular Neurosciences 35(2):320-327. Takei, Y. (2009) 'Phosphorylation of Nogo receptors suppresses Nogo signaling, allowing neurite regeneration', Science Signaling 2(64): ra14. Valentini, G., Maggi, M., Pey, A. L. (2013) 'Protein Stability, Folding and Misfolding in Human PGK1 Deficiency', Biomolecules 3(4):1030-1052. Vargas, M. R., Johnson D. A., Johnson J. A. (2011) 'Decreased glutathione accelerates neurological deficit and mitochondrial pathology in familial ALS-linked hSOD1G93A mice model', Neurobiology of Disease 43(3): 543–551. Van Blitterswijk, M., DeJesus-Hernandez, M., Rademakers, R. (2012) 'How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders', Current Neurology and Neuroscience Reports 25(6):689-700. Wang, K. C., Kim, J. A., Sivasankaran, R., Segal, R., He, Z. (2002) 'p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp', Nature 420(6911):74-78. Wang, H., Shen, J., Xiong, N., Zhao, H., Chen, Y. (2011) 'Protein kinase B is involved in Nogo-66 inhibiting neurite outgrowth in PC12 cells', Neuroreport 22(15): 733-738. Wang, B1., Xiao, Z., Chen, B., Han, J., Gao, Y., Zhang, J., Zhao, W., Wang, X., Dai, J. (2008) 'Nogo-66 promotes the differentiation of neural progenitors into astroglial lineage cells through mTORSTAT3 pathway', PLOS one 3(3): e1856. Wen, X., Tan, W., Westergard, T., Krishnamurthy, K., Markandaiah, S. S., Shi, Y., Lin, S., Shneider, N. A., Monaghan, J., Pandey, U. B., Pasinelli, P., Ichida, J. K., Trotti, D. (2014) 'Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death', Neuron 84(6):1213-1225. Wong, M., Martin, L. J. (2010) 'Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice', Human Molecular Genetics 19(11):2284-2302. Yang, Y. S., Strittmatter, S. M., (2007) 'The reticulons: a family of proteins with diverse functions', Genome Biology 8(12):23401-23410. Yasumoto, K., Koizumi, K., Kawashima, A., Saitoh, Y., Arita, Y., Shinohara, K., Minami, T., Nakayama, T., Sakurai, H., Takahashi, Y., Yoshie, O., Saiki, I. (2006) 'Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer', The Journal of Cancer Research 66(4):2181-2187. Zhang, D., Utsumi, T., Huang, H. C., Gao, L., Sangwung, P., Chung, C., Shibao, K., Okamoto, K,m Yamaguchi, K., Groszmann, R. J., Jozsef, L., Hao, Z., Sessa, W. C., Iwakiri, Y. (2011) 'Reticulon 4B (Nogo-B) is a novel regulator of hepatic fibrosis ', Hepatology 53(4): 1306-1315. Zhang, D., Tai, L. K., Wong, L. L., Chiu, L. L., Sethi, S. K., Koay, E. S. (2005) 'Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer', Molecular and Cellular Proteomics 4(11):1686-1696. Zieker, D., Konigsrainer, I., Weinreich, J., Beckert, S., Glatzle, J., Nieselt, K., Buhler, S., Loffler, M., Gaedcke, J., Northoff, H., Mannheim, J. G., Wiehr, S., Pichler, B. J., von Weyhern, C., Brucher, B. L., Konigsrainer, A. (2010) ' Phosphoglycerate kinase 1 promoting tumor progression and metastasis in gastric cancer - detected in a tumor mouse model using positron emission tomography/magnetic resonance imaging ', Cellular Physiology Biochemistry 26(2):147-154. Zieker, D., Konigsrainer, I., Traub, F., Nieselt, K., Knapp, B., Schillinger, C., Stirnkorb, C., Fend, F., Northoff, H., Kupka, S., Brucher, B. L., Konigsrainer, A. (2008) 'PGK1 a potential marker for peritoneal dissemination in gastric cancer', Cellular Physiology Biochemistry 21(5-6):429-436. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/60056 | - |
dc.description.abstract | 在ALS的病人中,其肌肉內的NogoA表現量會不正常的上升,但表現過量NogoA如何造成疾病的分子機制目前仍不清楚。因此我們建立了一個可以由Doxycycline誘導,在肌肉過量表現斑馬魚Rtn4a l(哺乳類NogoA的homology)的轉殖品系Tg (pZα:TetON-Rtn4a l )。經Doxycycline的誘導一週後,可觀察到neuromuscular junction denervation的現象;三週後,肌肉束發生necrosis的現象;並且誘導四週後的成魚體重也會減輕。這些結果顯示斑馬魚肌肉中若過量表現Rtn4a l,會使其出現與人類ALS疾病相似的病變進程。
另一方面,在先前的研究中獲知,表現過量NogoA的肌肉細胞株Sol8 (Sol8-NogoA),會減少其conditioned medium (CM)中P蛋白質的分泌量。若將運動神經細胞株NSC34培養在Sol8-NogA的CM中,其neurite的生長會受到抑制。而我們在Sol8-NogoA的CM中添加外源性的P蛋白質,發現外源性的P蛋白能夠改善因Sol8-NogoA CM所引發不利NSC34細胞其neurite生長的現象。此外,在正常肌肉細胞株(Sol8-vector)培養環境的CM,添加P蛋白的專一抗體以中和Sol8-vector CM中的P蛋白,並將NSC34培養在該溶液,發現會不利於NSC34其neurite的生長。這些結果證明P蛋白對於運動神經細胞株NSC34其neurite的生長是重要的。 更進一步,透過western blotting實驗,我們證明外源性添加的P蛋白,會使NSC34細胞內p-Limk1 S323的程度下降,進而使p-Cofilin S3的程度降低,讓神經細胞傾向於生長。但一般所知的NogoA其Nogo 66 domain下游的p-Limk1 T508的程度並不受影響。再來,我們在NSC34中分別過量表現兩種突變型的Limk1,如Limk1 T508V以及Limk1 S323A,使其與內生性的Limk1競爭,發現Limk1 T508V並不改變因P蛋白造成p-Cofilin S3程度降低的能力。反之,Limk1 S323A卻會讓外源性P蛋白促使下游p-Cofilin S3下降的能力受到影響。另外,我們以NSC34添加Nogo 66做為模擬神經生長受到抑制的平台,發現Nogo 66能使ROCK2的表現量、p-Limk1 T508、p-Limk1 S323以及下游p-Cofilin S3的程度上升,而外源性添加的P蛋白能夠透過p-Limk1 S323使Nogo 66引起的下游p-Cofilin S3上升的現象降低。同時,我們也證明Nogo 66 receptor (NgR)的抑制劑NAP2能使Nogo 66所引發的ROCK2的表現量、p-Limk1 T508、p-Limk1 S323以及下游p-Cofilin S3的程度上升的現象降低,但Pgk1卻不會使ROCK2表現量及p-Limk1 T508程度降低,說明Pgk1不影響NgR、ROCK2、p-Limk1 T508這個axis。這些結果證明:外源性P蛋白透過p-Limk1 S323位點來影響NSC34其neurite的生長是具有專一性。 最後,我們用western blotting證實Sol8-NogoA CM處理的細胞,其神經功能性markers (ChAT、Syn1)和分化傾向的markers (GAP43、MAP2)表現量都下降;但若外源性P蛋白的添加,能使ChAT、Syn1、GAP43以及MAP2的表現量都會回升。同時,細胞免疫螢光染色,也能在經P蛋白處理後的運動神經元突觸末端,偵測到較多功能性marker Syn1的訊號。總之,我們的結果證實了,NogoA在肌肉中過量表現會造成P蛋白分泌量減少,使得P蛋白影響p-Limk1 S323以及其下游p-Cofilin S3這個我們新發現的路徑的能力減弱,而造成運動神經元的病變。 | zh_TW |
dc.description.abstract | It has been reported that the protein level of muscle-specific NogoA is abnormally up-regulated in ALS patients. Since the animal model that is able to express NogoA in mature stage is less developed, we generated a zebrafish transgenic line Tg(pZα: TetON-Rtn4a l), which enables to conditionally expresses Rtn4a l in muscle after doxycycline induction. Results demonstrated that denervation at neuromuscular junction was observed after induction for one week; severe necrosis in myofibers was observed at the third week; and the weight of adult fish was greatly decreased at the fourth week. These dynamic phenotypes occurring in this transgenic line suggest that muscle-specific overexpression of Rtn4a1 in zebrafish model may exhibit similar symptoms that were suffered in human ALS disease.
The molecular mechanism underlying how over-expression of NogoA causes the ALS-like disease in zebrafish remains unclear. Previously we found that the Protein P was decreased in the condition medium (CM) obtained from culturing muscle cell line Sol8 which was over-expressed NogoA (Sol8-NogoA). In this continuous study, we demonstrated that the neurite outgrowth of neuron could also be retarded if neuron cell line NSC34 was cultured in Sol8-NogoA CM. When Protein P was directly added into Sol8-NogoA CM, the neurite outgrowth retardation occurred in NSC34 cells could be rescued. In contrast, when antiserum specifically against Protein P was added into Sol8-NogoA CM, the neurite outgrowth retardation of NSC34 remained intact, suggesting that Protein P is an essential factor for NSC 34 cells to grow neurites. Additionally, we proved that exogenous Protein P caused the decrease of the protein levels of p-Limk1 S323 and p-Cofiliin S3 in NSC34 cells; but that of p-Limk1 T508, which is the downstream of NogoA through Nogo 66 domain, remained unchanged, suggesting that the signal pathway affected by Protein P is independent of knowning Nogo 66 domain receptor (NgR1)-related pathways, including p-Limk1 T508. Furthermore, we constructed two mutated forms of Limk1 such as Limk1 T508V and S323A and transfected them to NSC34 cells. Results showed that the reduction of p-Cofilin S3 induced by Protein P was not altered by adding Limk1 T508V. Instead, the reduction of p-Cofilin S3 induced by Protein P was abolished by adding Limk1 S323A, suggesting that the normal function of endogenous Limk1 S323 in NSC34 was competed out by the mutated Limk1 S323A. We also found that addition of Nogo 66 caused the increase of ROCK2, p-Limk1 T508, p-Limk1 S323 and p-Cofilin S3. However, when Protein P was added, the levels p-Limk1 S323 and p-Cofilin S3 were decreased, suggesting that increasing p-Cofilin S3 induced by Nogo66 was ablated by Protein P through decreasing p-Limk1 S323. Meanwhile, when NAP2, a NgR1 blocking peptide, was added, the all levels of ROCK2, p-Limk1 S323, p-Limk1 T508 and p-Cofilin S3 were decreased due to no impacts of Nogo 66. Interestingly, when Protein P was added in the presence of NgR1, the levels of ROCK2 and p-Limk1 T508 did not change, suggesting that Protein P causes specifically the decrease of p-Cofilin S3 through p-Limk1 S323, which is independent of ROCK2/p-Limk1 T508 axis. Lastly, using Western blot analysis, we demonstrated that the expression levels of neuron differentiated markers MAP2 and GAP43 and the neuron functional markers Syn1 and ChAT were decreased in NSC34 cells treated with Sol8-NogoA CM. However, if Protein P was added in the Sol8-NogoA CM, the expression levels of MAP2, GAP43, Syn1 and ChAT were all increased. The Syn1 signal was also detected in the growth cone of NSC34 using immunostaining. demonstrated that NSC34 treated with exogenous P protein exhibited more Syn1 signal at growth cone. The line of above evidence, we concluded that when NogoA was over-expressed in muscle led to decrease the secretion of Protein P, causing to reduce the ability of Protein P to decrease p-Cofilin S3 through p-Limk1 S323, resulting in inhibiting the neurite outgrowth of NSC34 cells. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T09:53:16Z (GMT). No. of bitstreams: 1 ntu-105-R03b43022-1.pdf: 2214631 bytes, checksum: 2beb3da8b328367e54e502b9530c225f (MD5) Previous issue date: 2016 | en |
dc.description.tableofcontents | 目 錄
致謝…………………………………………………………………………………………………………… i 中文摘要…………………………………………………………………………………………………… iii 英文摘要………………………………………………………………………………………………….. v 文獻回顧………………………………………………………………………………………………….. 1 前言………………………………………………………………………………………………………….. 14 材料………………………………………………………………………………………………………….. 18 方法………………………………………………………………………………………………………….. 21 結果………………………………………………………………………………………………………….. 29 討論………………………………………………………………………………………………………….. 45 結論………………………………………………………………………………………………………….. 52 參考文獻………………………………………………………………………………………………….. 53 圖說………………………………………………………………………………………………………….. 69 | |
dc.language.iso | zh-TW | |
dc.title | 以老鼠細胞株以及斑馬魚探討在肌肉中過量表現NogoA其影響運動神經元生長的機制 | zh_TW |
dc.title | Using mouse cell line and zebrafish as models to study the mechanism of overexpressing NogoA in muscle which influences motor neuron growth | en |
dc.type | Thesis | |
dc.date.schoolyear | 105-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 管永恕(Yung-Shu Kuan),王致恬(Chih-Tien Wang),鄭邑荃(Yi-Cheng Cheng) | |
dc.subject.keyword | 肌肉NogoA,運動神經,肌萎縮性脊髓側索硬化症, | zh_TW |
dc.subject.keyword | NogoA,NSC34,motor neuron,ALS, | en |
dc.relation.page | 88 | |
dc.identifier.doi | 10.6342/NTU201700038 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2017-01-11 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 分子與細胞生物學研究所 | zh_TW |
顯示於系所單位: | 分子與細胞生物學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-105-1.pdf 目前未授權公開取用 | 2.16 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。